Glassman Wealth Services’s Twist Bioscience TWST Stock Holding History

Glassman Wealth Services’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-124	Closed	-$4.57K	–	1700
2023 Q4	$4.57K	Buy	124 +30	+32%	+$694	﹤0.01%	1109
2023 Q3	$1.9K	Hold	94	–	–	﹤0.01%	1344
2023 Q2	$1.92K	Buy	94 +49	+109%	+$734	﹤0.01%	1261
2023 Q1	$679	Buy	+45	New	+$994	﹤0.01%	1555
2022 Q4	–	Sell	-54	Closed	-$2K	–	2036
2022 Q3	$2K	Buy	54 +9	+20%	+$382	﹤0.01%	1271
2022 Q2	$2K	Buy	+45	New	+$1.59K	﹤0.01%	1296
2022 Q1	–	Sell	-9	Closed	-$1K	–	1955
2021 Q4	$1K	Sell	9 -15	-63%	-$1.54K	﹤0.01%	1520
2021 Q3	$3K	Buy	24 +17	+243%	+$1.95K	﹤0.01%	1102
2021 Q2	$1K	Buy	7 +3	+75%	+$349	﹤0.01%	1386
2021 Q1	$0	Buy	+4	New	+$607	﹤0.01%	1638
2019 Q3	–	Sell	-10	Closed	–	–	1377
2019 Q2	$0	Buy	+10	New	+$265	﹤0.01%	1370

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Glassman Wealth Services's TWST Position: Q1 2024 in Review

Glassman Wealth Services sold out of Twist Bioscience (TWST) in Q1 2024, closing a stake of 124 shares — an estimated $4.57K sold.

Glassman Wealth Services first reported a position in TWST in Q2 2019 and held it in 11 quarters. The position peaked at $4.57K in Q4 2023. 237 funds tracked by Wall St. Rank hold TWST as of Q1 2024.

Glassman Wealth Services reported no remaining Twist Bioscience position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 124 Twist Bioscience shares in Q1 2024, an estimated $4.57K.
Glassman Wealth Services first reported a position in Twist Bioscience in Q2 2019 and held it in 11 quarters.
Glassman Wealth Services's Twist Bioscience position peaked at $4.57K in Q4 2023.
237 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.